valvular heart disease ronald d’agostino, d.o., f.a.c.c., f.a.c.p. director of non-invasive...

200
Valvular Heart Disease Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine Manhasset, N.Y.

Upload: lester-thompson

Post on 18-Dec-2015

213 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Valvular Heart Disease Valvular Heart Disease

Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology

Long Island Cardiovascular and Internal Medicine Manhasset, N.Y.

Page 2: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 3: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 4: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 5: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 6: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 7: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Calcified Ao Valve 2nd to acquired AoV Stenosis

Page 8: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Severely calcified tricuspid valve from an elderly patient

Page 9: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 10: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Phonogram of a 20yoa women with moderate AoV congenital Phonogram of a 20yoa women with moderate AoV congenital stenosis with a bicuspid valve, presenting with an ejection click, stenosis with a bicuspid valve, presenting with an ejection click, increased A2 and systolic ejection murmurincreased A2 and systolic ejection murmur

Page 11: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Phonogram of a 20yoa male with severe non-calcified AoVS. Seen Phonogram of a 20yoa male with severe non-calcified AoVS. Seen here is a paradoxical splitting of S2, late systolic ejection murmur here is a paradoxical splitting of S2, late systolic ejection murmur and prominent S4. The LV is noted to have a low volume and a and prominent S4. The LV is noted to have a low volume and a slow up swing of the carotid pulse.slow up swing of the carotid pulse.

Page 12: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Apexcardiogram of the severe AoVS showing a Apexcardiogram of the severe AoVS showing a sustained “a” wave, causing a palpable S4 gallop (the sustained “a” wave, causing a palpable S4 gallop (the non-compliant ventricle)non-compliant ventricle)

Page 13: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

70yoa male with sever AoVS, note the absence of both the ejection click and Ao second sound (circled). Also there is a slow up swing of the carotid pulse.

Page 14: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 15: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

The window to the inner world – The Eyes– Note the multiple

calcific emboli in the retina of this elderly patient presenting with amaurosis fugax

– Patient was Dx with severe acquired AoVS

Page 16: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 17: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 18: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 19: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 20: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 21: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 22: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 23: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Catheter gradients are reported as peak to peak pressure differences

This is not a true measurement of pressure drop off across the AoV because they do not occur at the same time

Echocardiogram is ideal for pressure drop off across the valve

The two should be used together to evaluate the patient for validation studies

Peak to Peak pressure diff Pressure Drop off

Page 24: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 25: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Percutanous valvuloplasty with a prophylactic RV Percutanous valvuloplasty with a prophylactic RV Pacemaker to combat bradycardia during the procedurePacemaker to combat bradycardia during the procedure

Page 26: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Ross Ross ProcedureProcedure

Page 27: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Survival in the elderly (ave age of 60) after a AoV Survival in the elderly (ave age of 60) after a AoV replacement (AVR)replacement (AVR)

Page 28: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Pt with Marfan’s syndromePt with Marfan’s syndrome

Page 29: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Marfan’s with type-A Ao Marfan’s with type-A Ao dissection dissection

Page 30: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 31: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 32: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 33: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 34: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 35: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Growth the heart Growth the heart musclemuscle

A – Infant’s heart weighing about 15gm and LV is 7gm

B – Adult’s weighing 300gm and 100gm respectively

C – Athlete's is 500gms and 200gm

D – Concentric Hypertrophy – 650gms and 400gms

E – Decompensated Eccentric Hypertrophy – 900gms and 500gms – fewer myocytes are noted, replaced by fibrotic scar tissue

Page 36: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

rr hh

Page 37: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 38: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 39: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Pulse and Reflected wave Pulse and Reflected wave velocities in an elastic Aovelocities in an elastic Ao

Page 40: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

What about in a stiff aorta?What about in a stiff aorta?

Page 41: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 42: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 43: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 44: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 45: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 46: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 47: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 48: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 49: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 50: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 51: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 52: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 53: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Pre and Post op CXR of a patient with AoV Regurgitation

Note the decrease in long and short diameters from the Starr-Edwards valve replacement procedure

Page 54: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Typical LVH associated with AoVR with a strain pattern Typical LVH associated with AoVR with a strain pattern and tall T-wavesand tall T-waves

Page 55: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 56: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

LV wall stress can be reduced with ACE-I or hydralazines, but only ACE-I are noted to decrease LV mass index and improve EF’s more effectively

Page 57: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 58: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 59: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

% Survival Rates% Survival Rates

Page 60: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 61: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Patient with Patient with overt overt pulmonary pulmonary edema. Note edema. Note the the characteristic characteristic “batwing “batwing sign”sign” on the on the CXR – fluid CXR – fluid distributiondistribution

Page 62: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 63: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 64: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Top – myxomatous MVTop – myxomatous MVBottom – Nl MVBottom – Nl MV

Page 65: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 66: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 67: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 68: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 69: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Phonogram of severe FMV Phonogram of severe FMV and MVRand MVR

Page 70: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Echo of an FMP with MVP in Echo of an FMP with MVP in diastolediastole

Page 71: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Note the MV prolapsing into the LANote the MV prolapsing into the LA

Page 72: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

LV cineangiography in the RAO LV cineangiography in the RAO and LAO projectionand LAO projection

Page 73: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

LV Ventriculogram of a pt with MRLV Ventriculogram of a pt with MR

Page 74: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 75: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 76: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 77: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

It’s not just the heartIt’s not just the heart

S/S of FMV/MPV is a dynamic inter-relationship between the Cardiac, Neuroendocrine and Autonomic Nervous System

Page 78: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 79: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 80: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 81: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 82: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 83: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Phonogram with simultaneous ECG of a pt post MV Phonogram with simultaneous ECG of a pt post MV repair – note the absence of a murmur (pre-op below) repair – note the absence of a murmur (pre-op below)

Page 84: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 85: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 86: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 87: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Quick, what’s this ECG Quick, what’s this ECG showing?showing?

Page 88: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 89: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 90: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 91: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 92: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 93: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 94: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

B-S Single Tilting DiskB-S Single Tilting Disk

Page 95: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

M-H Single Tilting Disk – M-H Single Tilting Disk – Contains Contains

a Teflon sewing ring, titanium housing and carbon a Teflon sewing ring, titanium housing and carbon coated diskscoated disks

Page 96: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

St. Jude Bi-leaflet Tilting DiskSt. Jude Bi-leaflet Tilting Disk

Page 97: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

C-E Stented porcine C-E Stented porcine Bioprosthesis Bioprosthesis

Page 98: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Hancock II Stented Hancock II Stented BioprosthesisBioprosthesis

Page 99: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

C-E Stented Pericardial C-E Stented Pericardial BioprosthesisBioprosthesis

Page 100: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 101: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Toronto Stentless Porcine Toronto Stentless Porcine ValveValve

Page 102: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Ausculatory Finding With Prosthetic ValvesAusculatory Finding With Prosthetic Valves

Page 103: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 104: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

The St. Jude Heart Valve has regurgitant flow that is perpendicular to the valve

Regurgitation is noted at the disk margins and the extremes of the closure line

Page 105: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 106: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 107: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 108: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Prosthetic valves are prone to Prosthetic valves are prone to perforate perforate

Page 109: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 110: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 111: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 112: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 113: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

TEE of an endocarditis originating from the TEE of an endocarditis originating from the prosthetic valveprosthetic valve

Page 114: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Another ViewAnother View

Page 115: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 116: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 117: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 118: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 119: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 120: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 121: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Any one know what Any one know what Dressler’s syndrome is?Dressler’s syndrome is?

Page 122: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 123: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Vegetations on a MV 2Vegetations on a MV 2ndnd to Infective to Infective Endocarditis from Endocarditis from H. FluH. Flu

Page 124: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Strep. Sanguis (or any pathogen) can cause occlusive coronary Strep. Sanguis (or any pathogen) can cause occlusive coronary

embolization of the coronary ostiumembolization of the coronary ostium

Page 125: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Subungual Subungual hemorrhages hemorrhages (splinter (splinter hemorrhages)hemorrhages) are indicative of are indicative of AcuteAcute infective infective endocarditis endocarditis

Page 126: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

If you see needle tracks – think infective endocarditis If you see needle tracks – think infective endocarditis ((tricuspid perforation is common with IVDAtricuspid perforation is common with IVDA))

Page 127: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Does everybody see the vegetation on the Does everybody see the vegetation on the posterior leaflet, in this patient with severe posterior leaflet, in this patient with severe

MVP?MVP?

Page 128: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 129: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 130: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 131: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 132: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 133: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 134: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 135: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 136: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 137: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 138: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

HMO's    Two doctors and an HMO manager died and lined

up at the Pearly Gates for admission to Heaven.  St. Peter asked them to identify themselves.

    One doctor stepped forward and said, "I was a pediatric spine surgeon and helped kids overcome

their deformities."    St. Peter said, " You can enter."

    The second doctor said, "I was a psychiatrist. I helped people rehabilitate themselves."

    St. Peter also invited him in.    The third applicant stepped forward and said, "I

was an HMO manager and I helped people get cost-effective health care."

    St. Peter said, "You can come in too."    As the HMO manager walked by, St. Peter quietly

added, "But you can only stay three days... After that you can go to hell.

Page 139: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Valve SurgeryValve Surgery

Page 140: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Aortic StenosisAortic Stenosis

Indications for surgery:– Hemodynamically severe AS with or without

symptoms High risk of sudden death immediate surgery indicated

– Hemodynamically mild to moderate AS with symptoms

1/3 will die within 4 years Prompt surgery indicated

Page 141: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Indications for Surgery for Indications for Surgery for Severe Aortic StenosisSevere Aortic Stenosis

All Symptomatic Patients:

Normal LV: ASAP LV Dysfunction: Urgent Heart Failure: Emergent

Asymptomatic Patients:

All patients with AVA <0.75cm2

All patients with AVA 0.76-1.0cm2

Painless Ischemia Significant arrhythmias Severe LVH LV dysfunction

Page 142: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Aortic InsufficiencyAortic Insufficiency

Latent period to cardiac decompensation. Once deterioration begins LV fails rapidly

Sudden death is not common– Symptoms = prompt surgery– No symptoms = follow closely for decreased

LV function

Page 143: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Aortic Valve SurgeryAortic Valve Surgery

Repair:– Not often done. No long term results. – Replacement is procedure of choice

Replacement:– Procedure of choice– Mechanical Valve– Tissue Valve

Page 144: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Choosing a ValveChoosing a Valve

Ideal artifical valve would:– Be easy to implant– Last forever– Allow blood to flow easily thru central opening

& prevent reverse flow when closed– Be made from material that would not damage

cells or promote blood clot formation– Be easy to obtain

Page 145: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 146: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Selecting a ValveSelecting a Valve

When selecting a replacement valve the surgeon must:– Weigh the advantages & disadvantages of each

valve type.– Know patient’s lifestyle, age, size, medical

history & ability to tolerate anticoagulation

Page 147: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Caged Ball ValveCaged Ball Valve(Starr-Edwards)(Starr-Edwards)

Metal ball cage with struts mounted on ringInside cage is hollow metal or plastic ball

(poppet)The forward motion of blood forces the

poppet into the cage.Blood flows thru the cage & around poppet

Page 148: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 149: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Ball-CageBall-Cage

Advantages:– Durability

Disadvantages:– Prone to clot formation– Blood flow thru &

around poppet can cause clots to break free & enter blood stream

– Requires long-term anticoagulation

Page 150: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Tilting Disc ValveTilting Disc Valve

Made of pyrolytic carbonMobile lens-shaped disc attached to cirular

ring by 2 transverse struts.Disc tilts open 60-80 degrees allowing

blood to flow around the disc

Page 151: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 152: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Tilting DiscTilting Disc

Advantages:– Durability– Less blood flow

obstruction than caged-ball

Disadvantages:– Prone to clot formation– Long term

anticoagulation required

Page 153: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Bi-Leaflet ValveBi-Leaflet Valve

Newest mechanical valveMost common valve in USA2 pivoting semicircular discs mounted

directly to sewing ring. Discs open perpendicularly

Blood flows thru ring & around discs When closed the discs lie flat, preventing

regurgitant blood flow

Page 154: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 155: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Bi-Leaflet ValveBi-Leaflet Valve

Advantages:– Durability– Approximates normal

valve function

Disadvantages:– Prone to clot formation

(less than other mechanical valves)

– Requires long term anticoagulation

Page 156: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Tissue ValvesTissue Valves

Porcine Xenograft:

– Aortic valve of pig, harvested intact, preserved & mounted on sewing ring. When in place, blood flows almost unobstructed thru central opening.

Page 157: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Porcine XenograftPorcine Xenograft

Advantages:– No anticoagulation

required

Disadvantages:– Limited durability– Increased failure after

5-7 years

Page 158: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 159: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Pericardial XenograftPericardial Xenograft

Obtained from calf pericardium.3 leaflets formed from preserved

pericardium & mounted on Dacron frame. Blood flow is virtually unobstructed.Advantages & disadvantages same as

porcine xenograft

Page 160: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

HomograftHomograft

Frozen AV of human cadaver. Harvested valve is thawed, trimmed & sewn

into place. No mounting material is needed

Page 161: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

HomograftHomograft

Advantages:– Excellent

hemodynamics– Little risk of clot

formation– Rare need for

anticoagulation

Disadvantages:– Difficult to obtain– Limited durability– Only for AVR

Page 162: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Pulmonary AutograftPulmonary Autograft

Ross Procedure:– Subtitution of patient’s pulmonary valve for the

aortic valve.– Only replacement that is truly alive &

potentially able to last a normal lifetime without blood thinners

– Has been shown to grow with the rest of the body in young children

Page 163: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

AVRAVR

Median SternotomyCPBValve exposure/inspection of valve & root

surrounding to determine extent of diseaseValve is sizedChosen valve is sewn into placeWean from CPB

Page 164: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Steps in Aortic Valve Replacement:

Page 165: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Risk Factors for Survival After Risk Factors for Survival After AVRAVR

Increased ageDecreased LV functionCADEndocarditisMismatch of prosthesis & body sizeNYHA Functional statusAscending Aortic Aneurysm

Page 166: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Mitral StenosisMitral Stenosis

Indications for surgery:– Surgery not usually recommended in

asymptomatic patients– Patients with few symptoms that are otherwise

healthy should have surgery– Patients with severe MS should have surgery

Page 167: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Mitral InsufficiencyMitral Insufficiency

Indications for surgery are more complex than for Mitral Stenosis

Patients with MR become symptomatic only after LV function has been severely & irreversibly damaged (at which time surgical results are much less favorable)

Page 168: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Mitral Valve RepairMitral Valve Repair

Able to perform repair when:– Prominent opening snap, no valve calcification– Pliable leaflets, commissural fusion– Normal chordae & papillary muscle

Page 169: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Closed CommissurotomyClosed Commissurotomy

First mitral valve surgery to be performedFirst performed 1923; suggested as early as

1898Rarely performed today

Page 170: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Operative TechniqueOperative Technique

Left Antero-lateral thoracotomy Pericardial sac opened longitudinally Suture & tourniquet placed @ base of left atrial

appendage which is clamped & opened. Surgeon’s index finger is intoduced thru opening &

clamp removed so that the LA & MV can be digitally explored.

Transventricular dilator introduced thru small incision in LV

Page 171: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Closed Mitral Closed Mitral CommissurotomyCommissurotomy

Advantages:– Simple– Rapid– Cost-effective– Low likelihood of

ending in valve replacement

Disadvantages:– Restenosis rate varies

greatly– Not “exact science”– Limited use– High risk of intra-op

embolism

Page 172: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Open CommissurotomyOpen Commissurotomy

Median Sternotomy/CPBWide atrial incision made/valve exposedAnnulus, leaflets, commissures, chords &

papillary muscles examined & analyzedMV observed thru open atrium as ventricle is

filled under pressureDecision then made regarding reconstruction

or valve replacement

Page 173: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Mitral Valve Surgery

Page 174: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Open CommissurotomyOpen Commissurotomy

Advantages:– Relatively safe– Preferred to valve

replacement

Disadvantages:– Median Sternotomy– CPB

Page 175: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Ring AnnuloplastyRing Annuloplasty

The role of the ring annuloplasty is to:– Correct/prevent further annular dilatation– Increase leaflet coaptation– Reinforce annulus following repair– Keep tension off fragile suture lines

(scaffolding)– Restore the size & shape of valve orifice

Page 176: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

VALVE ANNULOPLASTY

Page 177: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

ValvuloplastyValvuloplasty

Used to relieve valvular stenosis in selected patients

Local anesthesia/mild sedationBalloon passed thru narrowed valve &

inflated.Provides long-term improvement in patients

with MS. Limited relief in AS

Page 178: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Mitral stenosis: catheter balloon commissurotomy

©Copyright Science Press Internet Services

Page 179: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Indications for Valve Indications for Valve ReplacementReplacement

EndocarditisAcute Ischemic Mitral RegurgeRheumatic Heart DiseaseDegeneration of valve

Page 180: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Mitral Valve ReplacementMitral Valve Replacement

Chest Wall Incisions:– Median Sternotomy (most common)– Right thoracotomy - (isolated for re-op MVR)– Left thoracotomy - rarely used

Page 181: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Mitral Valve ReplacementMitral Valve Replacement

Median Sternotomy (most common incision) CPB Mitral valve exposed & examined to determine

how much tissue to remove. Preservation of chordae tendonae

Valve is sized using sizing tool New valve is sewn into place, suture line

inspected, CPB weaned & chest closed

Page 182: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Chordal PreservationChordal Preservation

Evidence suggests that preservation of Chordae & posterior leaflet of MV is important in maintaining the normal LV function

Complete excision is necessary in:– Endocarditis with infected tissue– Heavily calcified valvular apparatus

Page 183: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

MVR FactsMVR Facts

MVR has higher mortality than AVR2 most important factors are LV function &

ageValves in mitral position degenerate faster

than aortic or tricuspid

Page 184: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Tricuspid & Mitral ValvesTricuspid & Mitral Valves

The tricuspid and mitral valves function as a unit because the atrium, fibrous rings, valvular tissue, chordae tendonae, papillary muscle and ventricular walls are connected.

Damage to any one of these 6 parts can alter the heart’s function significantly.

Page 185: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Valve Structure:

Page 186: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine
Page 187: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Causes of Valvular DiseaseCauses of Valvular Disease

Degenerative DiseaseRheumatic Heart DiseaseInfective EndocarditisComplication of Acute MI

Page 188: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Valve AreasValve Areas

– NORMAL VALUES

– Aortic Valve: 2.5-3.5cm2– Mitral Valve: 4-6cm2– Tricuspid Valve: 4-6cm2

Page 189: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

MV Narrows

LAP Increases LA

Dilates

Pulmonary VascularPressure Incrreases

RV EnlargementRA Enlargement

Pathophysiology of Mitral Stenosis:

Dyspnea, Pulmonary Edema

RV Failure

JVD, Liver Engorgement,Ascites, Peripheral Edema

Page 190: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Clinical FindingsClinical Findingsin Mitral Stenosisin Mitral Stenosis

Atrial Dysrrhythmias Diastolic Murmur Symptoms start when

Valve area < 1.5cm2

Increased RAP, PAP, PAWP

Decreased CO/CI Fatigue, Dyspnea,JVD Hoarseness,

Dysphagia

Page 191: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Ruptured Papillary Muscle

Page 192: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Clinical Findings in Clinical Findings in Mitral InsufficiencyMitral Insufficiency

Atrial Dysrhythmias Systolic murmur Elevated RAP, PAP &

PAWP

Decreased CO/CI Fatigue Dyspnea Crackles Peripheral Edema

Page 193: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Aortic StenosisAortic Stenosis

Cause:– Rheumatic– Non-Rheumatic

CongenitalDegenerative

Page 194: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Aortic StenosisAortic Stenosis

Pathophysiology of AS:AV

StenosisIncreased

LVP LVH

DecreasedCO

Increased LAPLA

Dilatation

RV Failure

Page 195: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Clinical Findings of ASClinical Findings of AS

Chest Pain Syncope Fatigue Dyspnea Symptoms start with

valve area <1.0cm2

Increased PAP, PAWP Decreased

CO/CI/SVR Narrowed pulse

pressure Systolic Murmur

Page 196: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Aortic RegurgitationAortic Regurgitation

Rheumatic Non-rheumatic -

Valvular– Endocarditis– Congenital– Blunt Chest Trauma– Degeneration– Rheumatoid Arthritis– Systemic Lupus

Aortic:– Disease of ascending

aorta: Syphillis Marfan’s syndrome Aortic Dissection Dilatation of ascending

aorta

Page 197: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Aortic InsufficiencyAortic Insufficiency

Backward flow into LVDecreased COLV Dilatation & Hypertrophy DevelopIncreased LAP & PAP/PAWPOver Time - Right sided Heart Failure

Page 198: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Clinical Findings: AIClinical Findings: AI

Chest Pain Palpitations Diastolic Murmur Nodding of Head Fatigue Dyspnea

Elevated PAP/PAWP Decreased CO/CI Widened Pulse

Pressure

Page 199: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Tricuspid StenosisTricuspid Stenosis

Etiology: Congenital, RHD, NeoplasmAtrial Arrhythmias, RA EnlargementPulsatile JVD, Peripheral Edema, Ascites,

Hepatomegaly

Page 200: Valvular Heart Disease Ronald D’Agostino, D.O., F.A.C.C., F.A.C.P. Director of Non-Invasive Cardiology Long Island Cardiovascular and Internal Medicine

Tricuspid InsufficiencyTricuspid Insufficiency

Etiology: Physiologic resulting from Left sided heart disease, Endocarditis, Neoplasm

S&S: Same as for TS, but less peripheral edema/more ascites, pulsatile liver